INOUE Jun 井上純

Researcher Number	50568326
Other IDs
Affiliation (based on the past Project Information) *help	2019 – 2022: 東京医科歯科大学, 難治疾患研究所, 准教授 2014 – 2018: 東京医科歯科大学, 難治疾患研究所, 講師 2010 – 2013: 東京医科歯科大学, 難治疾患研究所, 助教
Review Section/Research Field	Principal Investigator Pathological medical chemistry / Basic Section 50020:Tumor diagnostics and therapeutics-related / Basic Section 49010:Pathological biochemistry-related Except Principal Investigator Complex systems / Basic Section 50020:Tumor diagnostics and therapeutics-related / Tumor biology / Tumor diagnostics / Tumor diagnosis
Keywords	Principal Investigator オートファジー / 細胞死 / 自然退縮 / 神経芽腫 / 安全性評価 / バイオマーカー / 核酸抗癌薬 / マイクロRNA / 核酸医薬 / 腫瘍退縮 / ユビキチン / タンパク質分解 … More Except Principal Investigator … More マイクロRNA / ゲノム / オートファジー / エピゲノム / がん / 核酸医薬 / バイオマーカー / オミクス解析 / 分子標的薬 / DNAメチル化 / 癌抑制遺伝子 / 癌遺伝子 / 難治がん / オミクス / 分子標的治療 / システム生物学 / BETファミリ－蛋白 / DNA損傷修復 / BETファミリーBRD4 / 抗がん核酸製剤 / スーパーエンハンサー / miR-3140-3p / miR-1293 / DNA修復経路 / BRD4 / BETファミリー蛋白 / 抗癌性核酸医薬 / 癌 / 核酸創薬 / 既存薬再配置 / 浸潤・転移 / がん特性 / 核酸抗がん薬 / がん抑制型マイクロRNA / がん悪性特性 / DR / がん代謝異常 / がん細胞文脈 / DDS / 上皮間葉転換（EMT) / 細胞文脈 / chromothripsis / 全ゲノムシークエンス / 次世代型シークエンサー / HOC313 / 次世代シークエンサー / 口腔がん / DNA二重鎖切断 / マイクロビーム照射装置 / ゲノム不安定性 / ゲノム再構成 / 染色体粉砕 / Chromothripsis / ビメンチン / EMT / 治療標的 / p62 / 上皮間葉転換 / がん個別化医療 / 遺伝子ネットワーク / がん抑制遺伝子 / がん遺伝子 / 分子標的 / 薬剤耐性 / miRNA / NRF2 / バイオリソース / がん治療標的分子 / ゲノム・エピゲノム解析 Less

Optimization of miRNA therapeutics for clinical applicationPrincipal Investigator
- Principal Investigator
  
  井上純
- Project Period (FY)
  2021 – 2023
- Research Category
  
  Grant-in-Aid for Scientific Research (B)
- Review Section
  
  Basic Section 50020:Tumor diagnostics and therapeutics-related
- Research Institution
  Tokyo Medical and Dental University
Development of therapeutic strategy based on autophagy activity for cancer therapyPrincipal Investigator
- Principal Investigator
  
  Inoue Jun
- Project Period (FY)
  2018 – 2020
- Research Category
  
  Grant-in-Aid for Scientific Research (C)
- Review Section
  
  Basic Section 49010:Pathological biochemistry-related
- Research Institution
  Tokyo Medical and Dental University
Development of therapeutic miRNAs targeting BET family protein BRD4 for cancer
- Principal Investigator
  
  Inazawa Johji
- Project Period (FY)
  2018 – 2020
- Research Category
  
  Grant-in-Aid for Scientific Research (B)
- Review Section
  
  Basic Section 50020:Tumor diagnostics and therapeutics-related
- Research Institution
  Tokyo Medical and Dental University
Development of therapeutic strategy based on autophagy activity for cancer therapyPrincipal Investigator
- Principal Investigator
  
  INOUE Jun
- Project Period (FY)
  2015 – 2017
- Research Category
  
  Grant-in-Aid for Scientific Research (C)
- Research Field
  
  Pathological medical chemistry
- Research Institution
  Tokyo Medical and Dental University
Establishment of novel concept for cancer diagnostics and therapeutics based on the systematic comprehension of cellular context in cancer
- Principal Investigator
  
  Inazawa Johji
- Project Period (FY)
  2015 – 2019
- Research Category
  
  Grant-in-Aid for Scientific Research on Innovative Areas (Research in a proposed research area)
- Review Section
  
  Complex systems
- Research Institution
  Tokyo Medical and Dental University
Comprehensive understanding of molecular carcinogenesis through omics analysis and development of molecular diagnostics for personalized medicine
- Principal Investigator
  
  Johji Inazawa
- Project Period (FY)
  2013 – 2015
- Research Category
  
  Grant-in-Aid for Scientific Research (A)
- Research Field
  
  Tumor diagnostics
- Research Institution
  Tokyo Medical and Dental University
Chromothripsis-like pattern in cancer-cell genome after irradiation by a focused vertical micro-beam system, SPICE
- Principal Investigator
  
  INAZAWA Johji
- Project Period (FY)
  2013 – 2014
- Research Category
  
  Grant-in-Aid for Challenging Exploratory Research
- Research Field
  
  Tumor biology
- Research Institution
  Tokyo Medical and Dental University
Molecular mechanism of the spontaneous regression of neuroblastomaPrincipal Investigator
- Principal Investigator
  
  INOUE Jun
- Project Period (FY)
  2012 – 2014
- Research Category
  
  Grant-in-Aid for Scientific Research (C)
- Research Field
  
  Pathological medical chemistry
- Research Institution
  Tokyo Medical and Dental University
Integrative omics analysis to explore molecular targets and biomarkers for personalized medicine in cancer
- Principal Investigator
  
  INAZAWA Johji
- Project Period (FY)
  2010 – 2014
- Research Category
  
  Grant-in-Aid for Scientific Research on Innovative Areas (Research in a proposed research area)
- Review Section
  
  Complex systems
- Research Institution
  Tokyo Medical and Dental University
Development of diagnostic tools for personalized cancer medicine by genomic and epigenomic analyses
- Principal Investigator
  
  INAZAWA Johji
- Project Period (FY)
  2010 – 2012
- Research Category
  
  Grant-in-Aid for Scientific Research (A)
- Research Field
  
  Tumor diagnosis
- Research Institution
  Tokyo Medical and Dental University
Molecular mechanism of the spontaneous regression of neuroblastomaPrincipal Investigator
- Principal Investigator
  
  INOUE Jun
- Project Period (FY)
  2010 – 2011
- Research Category
  
  Grant-in-Aid for Young Scientists (B)
- Research Field
  
  Pathological medical chemistry
- Research Institution
  Tokyo Medical and Dental University

[Book] 医学の歩み：マイクロRNAを用いた核酸抗癌薬の開発2019
- Author(s)
  井上純、稲澤譲治
- Total Pages
  5
- Publisher
  医歯薬出版株式会社
- ISBN
- Data Source
  KAKENHI-PROJECT-18K06954
[Journal Article] Potential for reversing miR-634-mediated cytoprotective processes to improve efficacy of chemotherapy against oral squamous cell carcinoma2022
- Author(s)
  Tran PX, Inoue J, Harada H, Inazawa J
- Journal Title
  
  Molecular therapy - Oncolytics
  
  Volume: 24 Pages: 897-908
- DOI
  10.1016/j.omto.2022.02.002
- Peer Reviewed / Open Access
- Data Source
  KAKENHI-PROJECT-21H02781
[Journal Article] Identification of PDHX as a metabolic target for esophageal squamous cell carcinoma2021
- Author(s)
  Inoue Jun、Kishikawa Masahiro、Tsuda Hitoshi、Nakajima Yasuaki、Asakage Takahiro、Inazawa Johji
- Journal Title
  
  Cancer Science
  
  Volume: - Issue: 7 Pages: 2792-2802
- DOI
  10.1111/cas.14938
- Peer Reviewed / Open Access
- Data Source
  KAKENHI-PROJECT-18H02688
[Journal Article] miR-766-5p Targets Super-Enhancers by Downregulating CBP and BRD4.2021
- Author(s)
  Gen Y, Muramatsu T, Inoue J, Inazawa J.
- Journal Title
  
  Cancer Res.
  
  Volume: 81 Issue: 20 Pages: 5190-5201
- DOI
  10.1158/0008-5472.can-21-0649
- Peer Reviewed
- Data Source
  KAKENHI-PROJECT-19K07709, KAKENHI-PROJECT-21H02781
[Journal Article] Augmentation of lenvatinib efficacy by topical treatment of miR-634 ointment in anaplastic thyroid cancer2021
- Author(s)
  Kishikawa Masahiro, Inoue Jun, Hamamoto Hidetoshi, Kobayashi Katsunori, Asakage Takahiro, Inazawa Johji
- Journal Title
  
  Biochemistry and Biophysics Reports
  
  Volume: 26 Pages: 101009-101009
- DOI
  10.1016/j.bbrep.2021.101009
- Peer Reviewed / Open Access
- Data Source
  KAKENHI-PROJECT-18H02688, KAKENHI-PROJECT-21H02781
[Journal Article] Concurrent targeting of MAP3K3 and BRD4 by miR-3140-3p overcomes acquired resistance to BET inhibitors in neuroblastoma cells.2021
- Author(s)
  Liu C, Gen Y, Tanimoto K, Muramatsu T, Inoue J, Inazawa J.
- Journal Title
  
  Mol Ther Nucleic Acids.
  
  Volume: 25 Pages: 83-92
- DOI
  10.1016/j.omtn.2021.05.001
- Peer Reviewed / Open Access
- Data Source
  KAKENHI-PROJECT-19K07709, KAKENHI-PROJECT-21H02781
[Journal Article] Cancer-associated miRNAs and their therapeutic potential2021
- Author(s)
  Inoue J, Inazawa J
- Journal Title
  
  J Hum Genet.
  
  Volume: 66 Issue: 9 Pages: 937-945
- DOI
  10.1038/s10038-021-00938-6
- Peer Reviewed
- Data Source
  KAKENHI-PROJECT-21H02781
[Journal Article] miR-1293, a Candidate for miRNA-Based Cancer Therapeutics, Simultaneously Targets BRD4 and the DNA Repair Pathway2020
- Author(s)
  Takagawa Yuki、Gen Yasuyuki、Muramatsu Tomoki、Tanimoto Kousuke、Inoue Jun、Harada Hiroyuki、Inazawa Johji
- Journal Title
  
  Molecular Therapy
  
  Volume: 28 Issue: 6 Pages: 1494-1505
- DOI
  10.1016/j.ymthe.2020.04.001
- Peer Reviewed / Open Access
- Data Source
  KAKENHI-PROJECT-18H02688, KAKENHI-PROJECT-18K06954
[Journal Article] Therapeutic Potential of LNP-Mediated Delivery of miR-634 for Cancer Therapy2020
- Author(s)
  Gokita K, Inoue J, Ishihara H, Kojima K, Inazawa J
- Journal Title
  
  Molecular Therapy - Nucleic Acids
  
  Volume: 19 Pages: 330-338
- DOI
  10.1016/j.omtn.2019.10.045
- Peer Reviewed / Open Access
- Data Source
  KAKENHI-PROJECT-18K06954, KAKENHI-PLANNED-15H05908, KAKENHI-PROJECT-18H02688
[Journal Article] Improving the Efficacy of EGFR Inhibitors by Topical Treatment of Cutaneous Squamous Cell Carcinoma with miR-634 Ointment2020
- Author(s)
  Inoue Jun、Fujiwara Kyoko、Hamamoto Hidetoshi、Kobayashi Katsunori、Inazawa Johji
- Journal Title
  
  Molecular Therapy - Oncolytics
  
  Volume: 19 Pages: 294-307
- DOI
  10.1016/j.omto.2020.10.009
- Peer Reviewed / Open Access
- Data Source
  KAKENHI-PROJECT-18H02688, KAKENHI-PROJECT-18K06954
[Journal Article] Ovarian cancer therapeutic potential of glutamine depletion based on GS expression.2018
- Author(s)
  Furusawa A, Miyamoto M, Takano M, Tsuda H, Song YS, Aoki D, Miyasaka N, Inazawa J, Inoue J.
- Journal Title
  
  Carcinogenesis
  
  Volume: 印刷中 Issue: 6 Pages: 758-766
- DOI
  10.1093/carcin/bgy033
- Peer Reviewed / Open Access / Int'l Joint Research
- Data Source
  KAKENHI-PROJECT-15K08301, KAKENHI-PROJECT-16K14630, KAKENHI-PROJECT-18K06954, KAKENHI-PLANNED-15H05908, KAKENHI-PROJECT-18H02688
[Journal Article] miR-3140 suppresses tumor cell growth by targeting BRD4 via its coding sequence and downregulates the BRD4-NUT fusion oncoprotein2018
- Author(s)
  Tonouchi Erina、Gen Yasuyuki、Muramatsu Tomoki、Hiramoto Hidekazu、Tanimoto Kousuke、Inoue Jun、Inazawa Johji
- Journal Title
  
  Scientific Reports
  
  Volume: 8 Issue: 1 Pages: 4482-4482
- DOI
  10.1038/s41598-018-22767-y
- Peer Reviewed / Open Access
- Data Source
  KAKENHI-PROJECT-16K14630, KAKENHI-PROJECT-15K19040, KAKENHI-PLANNED-15H05908, KAKENHI-PROJECT-18H02688
[Journal Article] Subcloning and characterization of highly metastatic cells derived from human esophageal squamous cell carcinoma KYSE150 cells by in vivo selection.2017
- Author(s)
  Okuda M, Inoue J, Fujiwara N, Kawano T, Inazawa J
- Journal Title
  
  Oncotarget
  
  Volume: 印刷中
- Peer Reviewed / Acknowledgement Compliant / Open Access
- Data Source
  KAKENHI-PLANNED-15H05908
[Journal Article] miR-432 Induces NRF2 Stabilization by Directly Targeting KEAP12017
- Author(s)
  Akdemir Burak、Nakajima Yasuaki、Inazawa Johji、Inoue Jun
- Journal Title
  
  Molecular Cancer Research
  
  Volume: 15 Issue: 11 Pages: 1570-1578
- DOI
  10.1158/1541-7786.mcr-17-0232
- Peer Reviewed
- Data Source
  KAKENHI-PLANNED-15H05908, KAKENHI-PROJECT-15K08301, KAKENHI-PROJECT-16K14630
[Journal Article] Subcloning and characterization of highly metastatic cells derived from human esophageal squamous cell carcinoma KYSE150 cells by <i>in vivo</i> selection2017
- Author(s)
  Okuda Masafumi、Inoue Jun、Fujiwara Naoto、Kawano Tatsuyuki、Inazawa Johji
- Journal Title
  
  Oncotarget
  
  Volume: 8 Issue: 21 Pages: 34670-34677
- DOI
  10.18632/oncotarget.16668
- Peer Reviewed / Open Access
- Data Source
  KAKENHI-PLANNED-15H05908, KAKENHI-PROJECT-16K14630
[Journal Article] Autophagy is required for cell survival under L-asparaginase induced metabolic stress in acute lymphoblastic leukemia cells2017
- Author(s)
  akahashi H, Inoue J, Sakaguchi K, Tanakagi M, Mizutani S, and Inazawa J
- Journal Title
  
  Oncogene
  
  Volume: 印刷中 Issue: 30 Pages: 4267-4276
- DOI
  10.1038/onc.2017.59
- Peer Reviewed / Acknowledgement Compliant / Open Access / Int'l Joint Research
- Data Source
  KAKENHI-PROJECT-15K08301, KAKENHI-PLANNED-15H05908, KAKENHI-PROJECT-16K14630
[Journal Article] Autophagy is required for cell survival under L-asparaginase -induced metabolic stress in acute lymphoblastic leukemia cells.2017
- Author(s)
  Takahashi H, Inoue J*, Sakaguchi K, Takagi M, Mizutani S, Inazawa J
- Journal Title
  
  Oncogene
  
  Volume: 印刷中
- Peer Reviewed / Acknowledgement Compliant / Open Access
- Data Source
  KAKENHI-PLANNED-15H05908
[Journal Article] Down-regulation of LAPTM5 in human cancer cells2016
- Author(s)
  Nuylan M, Kawano T, Inazawa J, Inoue J
- Journal Title
  
  Oncitarget
  
  Volume: 7 Issue: 19 Pages: 28320-8
- DOI
  10.18632/oncotarget.8614
- Peer Reviewed / Acknowledgement Compliant / Open Access
- Data Source
  KAKENHI-PLANNED-15H05908, KAKENHI-PROJECT-25250019, KAKENHI-PROJECT-16K14630
[Journal Article] Diverse involvement of isoforms and gene aberrations of Akt in human lung carcinomas2015
- Author(s)
  Dobashi Y, Tsubochi H, Matsubara H, Inoue J, Inazawa J, Endo S, Ooi A
- Journal Title
  
  Cancer Sci
  
  Volume: - Issue: 6 Pages: 772-781
- DOI
  10.1111/cas.12669
- Peer Reviewed / Acknowledgement Compliant / Open Access
- Data Source
  KAKENHI-PLANNED-22134002, KAKENHI-PROJECT-25250019, KAKENHI-PROJECT-15K10270, KAKENHI-PROJECT-26460438, KAKENHI-PLANNED-15H05908, KAKENHI-PROJECT-25460452
[Journal Article] High expression of p62 protein is associated with poor prognosis and aggressive phenotypes in endometrial cancer2015
- Author(s)
  Iwadate R, Inoue J, Tsuda H, Takano H, Furuya K, Hirasawa A, Aoki D, Inazawa J
- Journal Title
  
  Am J Pathol
  
  Volume: -
- Peer Reviewed / Acknowledgement Compliant
- Data Source
  KAKENHI-PLANNED-22134002
[Journal Article] High Expression of p62 Protein Is Associated with Poor Prognosis and Aggressive Phenotypes in Endometrial Cancer.2015
- Author(s)
  3. Iwadate R, Inoue J, Tsuda H, Takano M, Furuya K, Hirasawa A, Aoki D, Inazawa J.
- Journal Title
  
  Am J Pathol.
  
  Volume: 185 Issue: 9 Pages: 2523-2533
- DOI
  10.1016/j.ajpath.2015.05.008
- Peer Reviewed / Acknowledgement Compliant
- Data Source
  KAKENHI-PROJECT-15K08301, KAKENHI-PLANNED-15H05908, KAKENHI-PROJECT-25250019, KAKENHI-PROJECT-25462609
[Journal Article] High expression of p62 protein is associated with poor prognosis and aggressive phenotypes in endometrial cancer2015
- Author(s)
  Iwadate R, Inoue J, Tsuda H, Takano H, Furuya K, Hirasawa A, Aoki D, Inazawa J
- Journal Title
  
  Am J Pathol
  
  Volume: -
- Peer Reviewed / Acknowledgement Compliant
- Data Source
  KAKENHI-PROJECT-25250019
[Journal Article] Mitochondrial Apoptosis Pathway and Enhances Chemotherapy-Induced Cytotoxicity.2015
- Author(s)
  2. Fujiwara N, Inoue J, Kawano T, Tanimoto K, Kozaki K, Inazawa J
- Journal Title
  
  Cancer Res.
  
  Volume: 75 Issue: 18 Pages: 3890-3901
- DOI
  10.1158/0008-5472.can-15-0257
- Peer Reviewed / Acknowledgement Compliant
- Data Source
  KAKENHI-PROJECT-15K08301, KAKENHI-PLANNED-15H05908, KAKENHI-PROJECT-25250019, KAKENHI-PROJECT-26670815, KAKENHI-PROJECT-26293067
[Journal Article] Significance of Akt activation and AKT gene increases in soft tissue tumors.2014
- Author(s)
  Dobashi Y, Inazawa J, et al.
- Journal Title
  
  Hum Pathol.
  
  Volume: 45 Issue: 1 Pages: 127-36
- DOI
  10.1016/j.humpath.2013.06.024
- Peer Reviewed
- Data Source
  KAKENHI-PLANNED-22134002, KAKENHI-PROJECT-23590409, KAKENHI-PROJECT-25250019, KAKENHI-PROJECT-25293088, KAKENHI-PROJECT-25460452, KAKENHI-PROJECT-25640062
[Journal Article] High Expression of SQSTM1/p62 Protein Is Associated with Poor Prognosis in Epithelial Ovarian Cancer2014
- Author(s)
  Iwadate R, Inoue J, Tsuda H, Takano M, Furuya K, Hirasawa A, Aoki D, Inazawa J
- Journal Title
  
  ACTA HISTOCHEMICA ET CYTOCHEMICA
  
  Volume: 47 Issue: 6 Pages: 295-301
- DOI
  10.1267/ahc.14048
- NAID
  130004902927
- ISSN
  0044-5991, 1347-5800
- Language
  English
- Peer Reviewed / Acknowledgement Compliant / Open Access
- Data Source
  KAKENHI-PLANNED-22134002, KAKENHI-PROJECT-24590372, KAKENHI-PROJECT-25250019
[Journal Article] The impact of miRNA-based molecular diagnostics and treatment of NRF2-stabilized tumors.2014
- Author(s)
  Yamamoto S, Inazawa J, et al.
- Journal Title
  
  Mol Cancer Res.
  
  Volume: 12 Issue: 1 Pages: 58-68
- DOI
  10.1158/1541-7786.mcr-13-0246-t
- Peer Reviewed
- Data Source
  KAKENHI-PLANNED-22134002, KAKENHI-PROJECT-23390077, KAKENHI-PROJECT-24300341, KAKENHI-PROJECT-24590372, KAKENHI-PROJECT-25250019, KAKENHI-PROJECT-25640062, KAKENHI-PROJECT-26293067, KAKENHI-PROJECT-26670815
[Journal Article] γ-Glutamylcyclotransferase as a novel immunohistochemical biomarker for the malignancy of esophageal squamous tumors.2014
- Author(s)
  Takemura K, Inazawa J, et al.
- Journal Title
  
  Hum Pathol.
  
  Volume: 45 Issue: 2 Pages: 331-41
- DOI
  10.1016/j.humpath.2013.09.009
- Peer Reviewed
- Data Source
  KAKENHI-PLANNED-22134002, KAKENHI-PROJECT-24590372, KAKENHI-PROJECT-25250019, KAKENHI-PROJECT-25640062
[Journal Article] A transcriptional variant of the LC3A gene is involved in autophagy and frequently inactivated in human cancers2012
- Author(s)
  Bai H, Inazawa J, et al
- Journal Title
  
  Oncogene
  
  Volume: (Epub ahead of print) Issue: 40 Pages: 4397-408
- DOI
  10.1038/onc.2011.613
- Peer Reviewed
- Data Source
  KAKENHI-PLANNED-22134002, KAKENHI-PROJECT-22240090, KAKENHI-PROJECT-22790309, KAKENHI-PROJECT-24590372
[Journal Article] Common variants at 11q12, 10q26 and 3p11.2 are associated with prostate cancer susceptibility in Japanese2012
- Author(s)
  赤松秀輔, 他
- Journal Title
  
  Nature Genetics
  
  Volume: 44 Issue: 4 Pages: 426-429
- DOI
  10.1038/ng.1104
- Peer Reviewed
- Data Source
  KAKENHI-PROJECT-10J02102, KAKENHI-PLANNED-22134002, KAKENHI-PROJECT-22240090, KAKENHI-PROJECT-22390302, KAKENHI-PROJECT-22390306, KAKENHI-PROJECT-23659752, KAKENHI-PROJECT-23791782, KAKENHI-PROJECT-24501364, KAKENHI-PROJECT-24590412, KAKENHI-PLANNED-22116010
[Journal Article] HECT-type ubiquitin ligase ITCH targets lysosomal- associated protein multispanningtransmembrane 5 (LAPTM5) and prevents LAPTM5-mediated cell death2011
- Author(s)
  Ishihara T, Inoue J, Kozaki K, Imoto I, Inazawa J
- Journal Title
  
  J Biol Chem
  
  Volume: 286 Issue: 51 Pages: 44086-94
- DOI
  10.1074/jbc.m111.251694
- Peer Reviewed
- Data Source
  KAKENHI-PROJECT-22240090, KAKENHI-PROJECT-23390077, KAKENHI-PROJECT-23390325
[Journal Article] HECT-type ubiquitin ligase ITCH targets lysosomal-associated protein multispanning transmembrane 5 (LAPTM5) and prevents LAPTM5-mediated cell death2011
- Author(s)
  Ishihara T, Inoue J, Kozaki K, Imoto I, Inazawa J
- Journal Title
  
  The Journal of Biological Chemistry
  
  Volume: 286 Pages: 44086-44094
- Peer Reviewed
- Data Source
  KAKENHI-PROJECT-22790309
[Journal Article] The HECT-type ubiquitin ligase ITCH targets lysosomal-associated protein multispanning transmembrane 5(LAPTM5) and prevents LAPTM5-mediated cell death2011
- Author(s)
  Ishihara T, Inoue J, Kozaki K, Imoto I, Inazawa J
- Journal Title
  
  J Biol Chem
  
  Volume: 286 Pages: 44086-44094
- Peer Reviewed
- Data Source
  KAKENHI-PROJECT-22790309
[Patent] 医薬組成物2020
- Inventor(s)
  稲澤　譲治、玄　泰之、井上　純、村松　智輝、高川　祐希
- Industrial Property Rights Holder
  国立大学法人東京医科歯科大学
- Industrial Property Rights Type
  特許
- Filing Date
  2020
- Overseas
- Data Source
  KAKENHI-PROJECT-18H02688
[Patent] 医薬組成物2019
- Inventor(s)
  稲澤譲治、玄泰之、井上純、村松智輝、高川祐希
- Industrial Property Rights Holder
  国立大学法人東京医科歯科大学
- Industrial Property Rights Type
  特許
- Industrial Property Number
  2019-233250
- Filing Date
  2019
- Data Source
  KAKENHI-PROJECT-18H02688
[Patent] 医薬組成物2019
- Inventor(s)
  稲澤譲治、玄泰之、井上純、村松智輝、高川祐希
- Industrial Property Rights Holder
  国立大学法人東京医科歯科大学
- Industrial Property Rights Type
  特許
- Industrial Property Number
  2019-233250
- Filing Date
  2019
- Data Source
  KAKENHI-PLANNED-15H05908
[Patent] マイクロRNAの測定方法、並びに、がん治療剤及びこれを含有するがん治療のための医薬組成物2018
- Inventor(s)
  稲澤譲治、井上純、山本信祐、河野辰幸、小崎健一
- Industrial Property Rights Holder
  国立大学法人東京医科歯科大学
- Industrial Property Rights Type
  特許
- Industrial Property Number
  2018-094747
- Filing Date
  2018
- Data Source
  KAKENHI-PROJECT-18H02688
[Patent] マイクロRNAの測定方法、並びに、がん治療剤及びこれを含有するがん治療のための医薬組成物2018
- Inventor(s)
  稲澤譲治、井上純、山本信祐、河野辰幸、小崎健一
- Industrial Property Rights Holder
  国立大学法人東京医科歯科大学
- Industrial Property Rights Type
  特許
- Filing Date
  2018
- Overseas
- Data Source
  KAKENHI-PLANNED-15H05908
[Patent] マイクロRNAの測定方法、並びに、がん治療剤及びこれを含有するがん治療のための医薬組成物2018
- Inventor(s)
  稲澤譲治、井上純、山本信祐、河野辰幸、小崎健一
- Industrial Property Rights Holder
  国立大学法人東京医科歯科大学
- Industrial Property Rights Type
  特許
- Filing Date
  2018
- Overseas
- Data Source
  KAKENHI-PROJECT-18H02688
[Patent] マイクロRNAの測定方法、並びに、がん治療剤及びこれを含有するがん治療のための医薬組成物2018
- Inventor(s)
  稲澤譲治、井上純、山本信祐、河野辰幸、小崎健一
- Industrial Property Rights Holder
  国立大学法人東京医科歯科大学
- Industrial Property Rights Type
  特許
- Industrial Property Number
  2018-094747
- Filing Date
  2018
- Data Source
  KAKENHI-PLANNED-15H05908
[Patent] がんに対する L-アスパラギナーゼ剤とオートファジー阻害剤の併用療法の効果の予測方法、及び、がん治療剤2016
- Inventor(s)
  稲澤譲治、井上純、高橋寛吉
- Industrial Property Rights Holder
  国立大学法人東京医科歯科大学
- Industrial Property Rights Type
  特許
- Filing Date
  2016-12-20
- Overseas
- Data Source
  KAKENHI-PLANNED-15H05908
[Patent] マイクロRNAの測定方法、並びに、がん治療剤及びこれを含有するがん治療のための医薬組成物2014
- Inventor(s)
  井上純、山本信祐、河野辰幸、小崎健一、稲澤譲治
- Industrial Property Rights Holder
  井上純、山本信祐、河野辰幸、小崎健一、稲澤譲治
- Industrial Property Rights Type
  特許
- Filing Date
  2014-02-17
- Overseas
- Data Source
  KAKENHI-PROJECT-24590372
[Patent] 神経芽腫の検出方法2012
- Inventor(s)
  稲澤譲治、井本逸勢、井上純
- Industrial Property Rights Holder
  国立大学法人東京医科歯科大学、富士フイルム株式会社
- Acquisition Date
  2012-07-10
- Overseas
- Data Source
  KAKENHI-PROJECT-22240090
[Patent] 神経芽腫の検出方法2012
- Inventor(s)
  稲澤譲治・井本逸勢・井上　純
- Industrial Property Rights Holder
  稲澤譲治・井本逸勢・井上　純
- Industrial Property Rights Type
  特許
- Filing Date
  2012-07-10
- Overseas
- Data Source
  KAKENHI-PROJECT-24590372
[Presentation] Identification of PDHX as a metabolic target for esophageal squamous cell carcinoma2021
- Author(s)
  Jun Inoue, Masahiro Kishikawa, Hitoshi Tsuda, Yasuaki Nakajima, Takahiro Asakage, and Johji Inazawa
- Organizer
  第80回日本癌学会
- Data Source
  KAKENHI-PROJECT-21H02781
[Presentation] Improving the efficacy of EGFR inhibitors by topical treatment of cutaneous squamous cell carcinoma with miR-634 ointment2021
- Author(s)
  Jun Inoue and Johji Inazawa
- Organizer
  第25回日本がん分子標的治療学会
- Data Source
  KAKENHI-PROJECT-21H02781
[Presentation] 食道癌における治療標的としての代謝関連分子の探索2020
- Author(s)
  井上純、岸川正大、朝蔭孝宏、稲澤譲治
- Organizer
  第79回日本癌学会学術総会
- Data Source
  KAKENHI-PROJECT-18H02688
[Presentation] LNPを介したmiR-634の腫瘍への送達による抗腫瘍効果2020
- Author(s)
  井上純、稲澤譲治
- Organizer
  第24回日本がん分子標的治療学会
- Data Source
  KAKENHI-PROJECT-18K06954
[Presentation] LNP を介した miR-634 の腫瘍への送達による抗腫瘍効果2020
- Author(s)
  井上純、稲澤譲治
- Organizer
  第24回日本がん分子標的治療学会
- Data Source
  KAKENHI-PROJECT-18H02688
[Presentation] Therapeutic potential of LNP-mediated delivery of miR-634 for cancer therapy2019
- Author(s)
  Inoue J, Gokita K, Kojima K, Inazawa J
- Organizer
  The 3rd International Symposium of International Society of Precision Cancer Medicine 2019
- Int'l Joint Research
- Data Source
  KAKENHI-PLANNED-15H05908
[Presentation] Therapeutic potential of LNP-mediated delivery of miR-634 for cancer therapy2019
- Author(s)
  Inoue J, Gokita K, Kojima K, Inazawa J
- Organizer
  The 3rd International Symposium of International Society of Precision Cancer Medicine 2019
- Data Source
  KAKENHI-PROJECT-18H02688
[Presentation] Therapeutic potential of the topical treatment of miR-634 ointment for skin cancer.2019
- Author(s)
  Kishikawa M, Inoue J, Asakage T, Inazawa J
- Organizer
  The 3rd International Symposium of International Society of Precision Cancer Medicine 2019
- Int'l Joint Research
- Data Source
  KAKENHI-PLANNED-15H05908
[Presentation] Therapeutic potential of the topical treatment of miR-634 ointment for skin cancer.2019
- Author(s)
  Kishikawa M, Inoue J, Asakage T, Inazawa J
- Organizer
  The 3rd International Symposium of International Society of Precision Cancer Medicine 2019
- Data Source
  KAKENHI-PROJECT-18H02688
[Presentation] The exploration of novel tumor suppressive miRNAs using function-based miRNA screening2019
- Author(s)
  Gen Y, Inoue J, Inazawa J.
- Organizer
  The 3rd International Symposium of International Society of Precision Cancer Medicine 2019
- Int'l Joint Research
- Data Source
  KAKENHI-PLANNED-15H05908
[Presentation] 核酸抗癌薬を目指した新規腫瘍抑制型 miRNA の探索2019
- Author(s)
  玄泰行、村松智輝、井上純、稲澤譲治
- Organizer
  第23回日本がん分子標的治療学会学術集会
- Data Source
  KAKENHI-PLANNED-15H05908
[Presentation] Ovarian cancer therapeutic potential of glutamine depletion based on GS expression2019
- Author(s)
  Furusawa A, Inoue J, Miyamoto M, Takano M, Tsuda H, Song YS, Aoki D, Miyasaka N, Inazawa J.
- Organizer
  The 3rd International Symposium of International Society of Precision Cancer Medicine 2019.
- Int'l Joint Research
- Data Source
  KAKENHI-PLANNED-15H05908
[Presentation] Therapeutic potential of the topical treatment of miR-634 ointment for cutaneous squamous cell carcinoma2019
- Author(s)
  Inoue J, Gokita K, Kishikawa M, Hamamoto H, Kobayashi K, Fujiwara K, Asakage T, Kojima K, Inazawa J
- Organizer
  AACR Annual Meeting 2019
- Int'l Joint Research
- Data Source
  KAKENHI-PROJECT-18H02688
[Presentation] Therapeutic potential of the topical treatment of miR-634 ointment for cutaneous squamous cell carcinoma2019
- Author(s)
  Inoue J, Gokita K, Kishikawa M, Hamamoto H, Kobayashi K, Fujiwara K, Asakage T, Kojima K, Inazawa J
- Organizer
  AACR Annual Meeting 2019
- Int'l Joint Research
- Data Source
  KAKENHI-PLANNED-15H05908
[Presentation] 甲状腺未分化癌に対する miR-634 を用いた核酸抗癌剤の開発2019
- Author(s)
  岸川正大、井上純、濱本英利、小林勝則、朝蔭孝宏、稲澤譲治
- Organizer
  第78回日本癌学会学術総会
- Data Source
  KAKENHI-PROJECT-18H02688
[Presentation] 新規癌抑制型 miRNA による MYC 標的核酸抗癌治療の可能性2019
- Author(s)
  玄泰行、村松智輝、井上純、稲澤譲治
- Organizer
  第78回日本癌学会学術総会
- Data Source
  KAKENHI-PROJECT-18H02688
[Presentation] 皮膚扁平上皮癌におけるmiR-634軟膏による抗腫瘍効果2019
- Author(s)
  井上純、岸川正大、濱本英利、小林勝則、藤原恭子、稲澤譲治
- Organizer
  第78回日本癌学会学術総会
- Data Source
  KAKENHI-PROJECT-18K06954
[Presentation] 核酸抗癌薬を目指した新規腫瘍抑制型 miRNA の探索2019
- Author(s)
  玄泰行、村松智輝、井上純、稲澤譲治
- Organizer
  第23回日本がん分子標的治療学会学術集会
- Data Source
  KAKENHI-PROJECT-18H02688
[Presentation] 新規癌抑制型 miRNA による MYC 標的核酸抗癌治療の可能性2019
- Author(s)
  玄泰行、村松智輝、井上純、稲澤譲治
- Organizer
  第78回日本癌学会学術総会
- Data Source
  KAKENHI-PLANNED-15H05908
[Presentation] 膚扁平上皮癌における miR-634 軟膏による抗腫瘍効果2019
- Author(s)
  井上純、岸川正大、濱本英利、小林勝則、藤原恭子、稲澤譲治
- Organizer
  第78回日本癌学会学術総会
- Data Source
  KAKENHI-PLANNED-15H05908
[Presentation] 状腺未分化癌に対する miR-634 を用いた核酸抗癌剤の開発2019
- Author(s)
  岸川正大、井上純、濱本英利、小林勝則、朝蔭孝宏、稲澤譲治
- Organizer
  第78回日本癌学会学術総会
- Data Source
  KAKENHI-PLANNED-15H05908
[Presentation] 皮膚扁平上皮癌における miR-634 軟膏による抗腫瘍効果2019
- Author(s)
  井上純、岸川正大、濱本英利、小林勝則、藤原恭子、稲澤譲治
- Organizer
  第78回日本癌学会学術総会
- Data Source
  KAKENHI-PROJECT-18H02688
[Presentation] The exploration of novel tumor suppressive miRNAs using function-based miRNA screening2019
- Author(s)
  Gen Y, Inoue J, Inazawa J
- Organizer
  The 3rd International Symposium of International Society of Precision Cancer Medicine 2019
- Data Source
  KAKENHI-PROJECT-18H02688
[Presentation] グルタミン合成酵素の発現に基づいた細胞外グルタミン枯渇による卵巣がん治療戦略の開発2018
- Author(s)
  井上純、古澤啓子、宮本守員、高野政志、津田均、Song Yong Sang、青木大輔、宮坂尚幸、稲澤譲治
- Organizer
  第77回日本癌学会学術総会
- Data Source
  KAKENHI-PROJECT-18H02688
[Presentation] 皮膚癌に対するmiR-634軟膏の塗布による抗腫瘍効果2018
- Author(s)
  岸川正大、井上純、濱本英利、小林勝則、藤原恭子、朝蔭孝宏、稲澤譲治
- Organizer
  第77回日本癌学会学術総会
- Data Source
  KAKENHI-PROJECT-18H02688
[Presentation] 皮膚癌に対するmiR-634軟膏の塗布による抗腫瘍効果2018
- Author(s)
  岸川正大、井上純、濱本英利、小林勝則、藤原恭子、朝蔭孝宏、稲澤譲治
- Organizer
  大阪国際会議場. 大阪. 2018年9月28日
- Data Source
  KAKENHI-PLANNED-15H05908
[Presentation] miR-3140 suppresses tumor cell growth by targeting BRD4 via its coding sequence and downregulates the BRD4-NUT fusion oncoprotein2018
- Author(s)
  Muramatsu T, Tonouchi E, Gen Y, Hiramoto H, Tanimoto K, Inoue J, Inazawa J
- Organizer
  AACR Annual Meeting 2018
- Data Source
  KAKENHI-PROJECT-18H02688
[Presentation] 機能的miRNAスクリーニングを用いた、p53不活性型癌に細胞死を誘導するmiRNAの探索2018
- Author(s)
  玄泰行、井上純、稲澤譲治
- Organizer
  第77回日本癌学会学術総会
- Data Source
  KAKENHI-PLANNED-15H05908
[Presentation] LNPを介したmiR-634の送達による抗腫瘍効果2018
- Author(s)
  五木田憲太郎、井上純、石原比呂之、小嶋一幸、稲澤譲治
- Organizer
  第77回日本癌学会学術総会
- Invited
- Data Source
  KAKENHI-PROJECT-18H02688
[Presentation] 機能的miRNAスクリーニングを用いた、p53不活性型癌に細胞死を誘導するmiRNAの探索2018
- Author(s)
  玄泰行、井上純、稲澤譲治
- Organizer
  第77回日本癌学会学術総会
- Data Source
  KAKENHI-PROJECT-18H02688
[Presentation] miR-3140 suppresses tumor cell growth by targeting BRD4 via its coding sequence and downregulates the BRD4-NUT fusion oncoprotein2018
- Author(s)
  Muramatsu T, Tonouchi E, Gen Y, Hiramoto H, Tanimoto K, Inoue J, Inazawa J
- Organizer
  AACR Annual Meeting 2018
- Int'l Joint Research
- Data Source
  KAKENHI-PLANNED-15H05908
[Presentation] Ovarian cancer therapeutic potential of glutamine depletion based on GS expression2018
- Author(s)
  Furusawa A, Inoue J, Miyamoto M, Takano M, Tsuda H, Song YS, Aoki D, Miyasaka N, Inazawa J
- Organizer
  AACR Annual Meeting 2018
- Data Source
  KAKENHI-PROJECT-18H02688
[Presentation] グルタミン合成酵素の発現に基づいた細胞外グルタミン枯渇による卵巣がん治療戦略の開発2018
- Author(s)
  井上純、古澤啓子、宮本守員、高野政志、津田均、Song Yong Sang、青木大輔、宮坂尚幸、稲澤譲治
- Organizer
  第77回日本癌学会学術総会
- Data Source
  KAKENHI-PROJECT-18K06954
[Presentation] LNPを介したmiR-634の送達による抗腫瘍効果2018
- Author(s)
  五木田憲太郎、井上純、石原比呂之、小嶋一幸、稲澤譲治
- Organizer
  第77回日本癌学会学術総会
- Data Source
  KAKENHI-PLANNED-15H05908
[Presentation] グルタミン合成酵素の発現に基づいた細胞外グルタミン枯渇による卵巣がん治療戦略の開発2018
- Author(s)
  井上純、古澤啓子、宮本守員、高野政志、津田均、Song Yong Sang、青木大輔、宮坂尚幸、稲澤譲治
- Organizer
  第77回日本癌学会学術総会
- Data Source
  KAKENHI-PLANNED-15H05908
[Presentation] Omics analysis of autophagic system for development of cancer therapy2017
- Author(s)
  Jun Inoue and Johji Inazawa
- Organizer
  第62回日本人類遺伝学会
- Invited
- Data Source
  KAKENHI-PROJECT-15K08301
[Presentation] Molecular basis for autophagy-based cancer therapy2017
- Author(s)
  Jun Inoue and Johji Inazawa
- Organizer
  第76回日本癌学会
- Data Source
  KAKENHI-PROJECT-15K08301
[Presentation] Differential requirement of amino acids on cell survival of ovarian cancer cells2017
- Author(s)
  Furusawa A, Inoue J, Tsuda H, Miyasaka N, Inazawa J
- Organizer
  108th annual meeting of American Association for Cancer Research 2017
- Int'l Joint Research
- Data Source
  KAKENHI-PLANNED-15H05908
[Presentation] 卵巣癌細胞の生存におけるアミノ酸要求性2017
- Author(s)
  古澤啓子、井上純、津田均、宮坂尚幸、稲澤譲治
- Organizer
  第76 回日本癌学会学術総会
- Data Source
  KAKENHI-PLANNED-15H05908
[Presentation] Autophagy is required for cell survival under L-asparaginase-induced metabolic stress in acute lymphoblastic leukemia cells2017
- Author(s)
  Inoue J, Takahashi H, Sakaguchi K, Takagi M, Mizutani S, Inazawa J
- Organizer
  108th annual meeting of American Association for Cancer Research 2017
- Int'l Joint Research
- Data Source
  KAKENHI-PLANNED-15H05908
[Presentation] Impairment of autophagy pathway in human cancer2017
- Author(s)
  Jun Inoue and Johji Inazawa
- Organizer
  AACR2017
- Int'l Joint Research
- Data Source
  KAKENHI-PROJECT-15K08301
[Presentation] High expression of MiR-432-3p is associated with the chemoresistance by NRF2 stabilization via directly targeting KEAP12017
- Author(s)
  Akdemir B, Inoue J, Kawano T, Inazawa J
- Organizer
  108th annual meeting of American Association for Cancer Research 2017
- Int'l Joint Research
- Data Source
  KAKENHI-PLANNED-15H05908
[Presentation] 機能的miRNA スクリーニングを用いた、p53 不活性型癌に細胞死を誘導する miRNA の探索2017
- Author(s)
  玄泰行、井上純、稲澤譲治
- Organizer
  第76 回日本癌学会学術総会
- Data Source
  KAKENHI-PLANNED-15H05908
[Presentation] オートファジーを指標とした癌治療戦略の分子基盤2017
- Author(s)
  井上純、稲澤譲治
- Organizer
  第76 回日本癌学会学術総会
- Data Source
  KAKENHI-PLANNED-15H05908
[Presentation] High expression of miR-432-3p is involved in NRF2 stabilization by directly targeting KEAP12017
- Author(s)
  Burak Akdemir、中島康晃、稲澤譲治、井上純
- Organizer
  第76 回日本癌学会学術総会
- Data Source
  KAKENHI-PLANNED-15H05908
[Presentation] Essential role of oxaloacetate and autophagy in L-asparaginase-treated leukemia cells2016
- Author(s)
  高橋寛吉、井上純、坂口公祥、高木正稔、水谷修紀、稲澤譲治
- Organizer
  第78回日本血液学会学術集会
- Place of Presentation
  パシフィコ横浜
- Year and Date
  2016-10-13
- Data Source
  KAKENHI-PLANNED-15H05908
[Presentation] 細胞生存システムを標的としたがん治療戦略2016
- Author(s)
  井上純
- Organizer
  第14回 TOkushima Young Investigators Conference
- Place of Presentation
  徳島大学病院西病棟11階日亜メディカルホール
- Year and Date
  2016-09-15
- Invited
- Data Source
  KAKENHI-PLANNED-15H05908
[Presentation] 卵巣癌細胞株の細胞生存におけるアミノ酸要求性2016
- Author(s)
  古澤啓子、井上純、久保田俊郎、稲澤譲治
- Organizer
  第75回日本癌学会学術総会
- Place of Presentation
  パシフィコ横浜
- Year and Date
  2016-10-07
- Data Source
  KAKENHI-PLANNED-15H05908
[Presentation] MicroRNA-based diagnosis and therapy in NRF2-stabilized tumor2016
- Author(s)
  Inoue J, Fujiwara N, Yamamoto S, Kawano T, Inazawa J
- Organizer
  AACR
- Place of Presentation
  New Orleans, USA
- Year and Date
  2016-04-18
- Int'l Joint Research
- Data Source
  KAKENHI-PROJECT-25250019
[Presentation] MicroRNA-based diagnosis and therapy in NRF2-stabilized tumor2016
- Author(s)
  Jun Inoue, Naoto Fujiwara, Shinsuke Yamamoto, Tatsuyuki Kawano, and Johji Inazawa
- Organizer
  AAR2016
- Place of Presentation
  ニューオリンズ、米国
- Year and Date
  2016-04-16
- Data Source
  KAKENHI-PROJECT-15K08301
[Presentation] ヒト癌におけるオートファジー経路の障害2016
- Author(s)
  井上純、稲澤譲治
- Organizer
  第75回日本癌学会学術総会
- Place of Presentation
  パシフィコ横浜
- Year and Date
  2016-10-07
- Data Source
  KAKENHI-PLANNED-15H05908
[Presentation] 癌におけるオートファジー障害2016
- Author(s)
  井上　純、稲澤譲治
- Organizer
  第75回日本癌学会
- Place of Presentation
  パシフィコ横浜
- Year and Date
  2016-10-06
- Data Source
  KAKENHI-PROJECT-15K08301
[Presentation] 急性リンパ性白血病細胞におけるL-asparaginase投与時のオキサロ酢酸とオートファジーの役割2016
- Author(s)
  高橋寛吉、井上純、坂口公祥、高木正稔、水谷修紀、稲澤譲治
- Organizer
  第75回日本癌学会学術総会
- Place of Presentation
  パシフィコ横浜
- Year and Date
  2016-10-06
- Data Source
  KAKENHI-PLANNED-15H05908
[Presentation] MicroRNA-based diagnosis and therapy in NRF2-stabilized tumor2016
- Author(s)
  Inoue J, Fujiwara N, Yamamoto S, Kawano T, Inazawa J
- Organizer
  AACR
- Place of Presentation
  New Orleans, USA
- Year and Date
  2016-04-18
- Int'l Joint Research
- Data Source
  KAKENHI-PLANNED-15H05908
[Presentation] MicroRNA-based diagnosis and therapy in NRF2-stabilized tumor2016
- Author(s)
  Inoue J, Fujiwara N, Yamamoto S, Kawano T, Inazawa J
- Organizer
  AACR2016 Annual Meeting
- Place of Presentation
  New Orleans, USA
- Year and Date
  2016-04-18
- Int'l Joint Research
- Data Source
  KAKENHI-PLANNED-15H05908
[Presentation] 食道扁平上皮癌の転移におけるLipocalin2の関与2016
- Author(s)
  奥田将史、井上純、河野辰幸、稲澤譲治
- Organizer
  第75回日本癌学会学術総会
- Place of Presentation
  パシフィコ横浜
- Year and Date
  2016-10-06
- Data Source
  KAKENHI-PLANNED-15H05908
[Presentation] Inactivation of LAPTM5 gene in human cancer2015
- Author(s)
  Michelle N､Inoue J、Inazawa J
- Organizer
  The 34th Sapporo International Cancer Symposium
- Place of Presentation
  ロイトン札幌, 札幌
- Year and Date
  2015-05-26
- Int'l Joint Research
- Data Source
  KAKENHI-PROJECT-25250019
[Presentation] Autophagy modulatorのハイコンテントスクリーニング系の構築2015
- Author(s)
  井上　純、稲澤譲治
- Organizer
  第73回日本癌学会
- Place of Presentation
  名古屋国際会議場（愛知・名古屋）
- Year and Date
  2015-10-08
- Data Source
  KAKENHI-PROJECT-15K08301
[Presentation] MicroRNA-based diagnosis and therapy in NRF2-stabilized tumor2015
- Author(s)
  Jun Inoue, Johji Inazawa
- Organizer
  Symposium in Cancer Preventive Material Development Research Cencer (CPMDRC)
- Place of Presentation
  Kyung Hee University（ソウル、韓国）
- Year and Date
  2015-10-23
- Invited
- Data Source
  KAKENHI-PROJECT-15K08301
[Presentation] Autophagy modulatorのハイコンテントスクリーニング系の構築2015
- Author(s)
  井上　純、稲澤譲治
- Organizer
  第60回日本人類遺伝学会
- Place of Presentation
  京王プラザホテル（東京・新宿）
- Year and Date
  2015-10-14
- Data Source
  KAKENHI-PROJECT-15K08301
[Presentation] Screening of autophagy modulators for cancer therapy using high-content imaging system2015
- Author(s)
  Inoue J、Inazawa J
- Organizer
  The 34th Sapporo International Cancer Symposium
- Place of Presentation
  ロイトン札幌, 札幌
- Year and Date
  2015-05-26
- Int'l Joint Research
- Data Source
  KAKENHI-PROJECT-25250019
[Presentation] Assessment of autophagy status for cancer therapy2013
- Author(s)
  井上　純、稲澤譲治
- Organizer
  第72回日本癌学会学術総会
- Place of Presentation
  パシフィコ横浜
- Data Source
  KAKENHI-PROJECT-24590372
[Presentation] HECT-type ubiquitin ligase ITCH targets lysosomal-associated protein multispanning transmembrane 5 (LAPTM5) and prevents LAPTM5-mediated cell death.2012
- Author(s)
  井上純、稲澤讓治　他
- Organizer
  American Association for Cancer Research, 103th Annual Meeting 2012.
- Place of Presentation
  Chicago, USA.
- Data Source
  KAKENHI-PROJECT-22240090
[Presentation] ヒト癌におけるオートファジー関連遺伝子の異常.2012
- Author(s)
  井上純、稲澤讓治
- Organizer
  第71回日本癌学会学術総会
- Place of Presentation
  さっぽろ芸文館(北海道)
- Year and Date
  2012-09-19
- Data Source
  KAKENHI-PLANNED-22134002
[Presentation] HECT-type ubiquitin ligase ITCH targets lysosomal-associated protein multispanning transmembrane 5 (LAPTM5) and prevents LAPTM5-mediated cell death.2012
- Author(s)
  井上純、稲澤讓治　他
- Organizer
  American Association for Cancer Research, 103th Annual Meeting 2012.
- Place of Presentation
  Chicago, USA.
- Year and Date
  2012-04-01
- Data Source
  KAKENHI-PLANNED-22134002
[Presentation] ヒト癌におけるオートファジー関連遺伝子の異常2012
- Author(s)
  井上　純、稲澤讓治
- Organizer
  日本癌学会学術総会
- Place of Presentation
  さっぽろ芸文館　北海道
- Data Source
  KAKENHI-PROJECT-24590372
[Presentation] 癌におけるオートファジー関連遺伝子LC3Avariant-1の不活性化2011
- Author(s)
  井上純、稲澤譲治, 他
- Organizer
  第70回日本癌学会学術総会
- Place of Presentation
  名古屋国際会議場(愛知)
- Year and Date
  2011-10-04
- Data Source
  KAKENHI-PLANNED-22134002
[Presentation] 食道癌におけるオートファジーATG7の不活性化2011
- Author(s)
  小西博貴、井上純、市野瀬志津子、津田均、河野辰幸、市川大輔、大辻英吾、井本逸勢、稲澤讓治
- Organizer
  第70回日本癌学会学術総会
- Place of Presentation
  名古屋国際会議場.愛知
- Year and Date
  2011-10-04
- Data Source
  KAKENHI-PROJECT-22790309
[Presentation] 癌におけるオートファジー関連遺伝子LC3 Avariant-1の不活性化2011
- Author(s)
  井上純、白樺、河野辰幸、稲澤讓治
- Organizer
  第70回日本癌学会学術総会
- Place of Presentation
  名古屋国際会議場
- Year and Date
  2011-10-04
- Data Source
  KAKENHI-PROJECT-22790309
[Presentation] 癌におけるオートファジー関連遺伝子LC3Avariant-1の不活性化2011
- Author(s)
  井上純、稲澤讓治, 他
- Organizer
  第70回日本癌学会学術総会
- Place of Presentation
  名古屋国際会議場(愛知)
- Year and Date
  2011-10-04
- Data Source
  KAKENHI-PROJECT-22240090
[Presentation] 癌におけるオートファジー関連遺伝子LC3Avariant-1の不活性化2011
- Author(s)
  井上純、白樺、河野辰幸、稲澤讓治
- Organizer
  第70回日本癌学会学術総会
- Place of Presentation
  名古屋国際会議場.愛知
- Year and Date
  2011-10-04
- Data Source
  KAKENHI-PROJECT-22790309
[Presentation] 癌細胞におけるオートファジー経路の障害2010
- Author(s)
  井上純、稲澤譲治
- Organizer
  第69回日本癌学会学術総会
- Place of Presentation
  シンポジウム「癌とオートファジー」大阪国際会議場・リーガロイヤルホテル.大阪
- Year and Date
  2010-09-23
- Data Source
  KAKENHI-PROJECT-22790309
[Presentation] Lysosomal-associated protein multispanning transmembrane 5 gene(LAPTM5) is associated with spontaneous regression of neuroblastomas2010
- Author(s)
  井上純、稲澤譲治, 他
- Organizer
  101th annual meeting of American Association for Cancer Research 2010
- Place of Presentation
  Washington, DC, USA
- Data Source
  KAKENHI-PROJECT-22240090
[Presentation] ヒト癌におけるLC3A variant-1の発現低下の意義2010
- Author(s)
  白樺、井上純、井本逸勢、稲澤讓治
- Organizer
  第69回日本癌学会学術総会
- Place of Presentation
  大阪国際会議場・リーガロイヤルホテル.大阪
- Year and Date
  2010-09-22
- Data Source
  KAKENHI-PROJECT-22790309
[Presentation] 癌細胞におけるオートファジー経路の障害.第69回日本癌学会学術総会2010
- Author(s)
  井上純、稲澤譲治
- Organizer
  第69回日本癌学会学術総会
- Place of Presentation
  大阪国際会議場・リーガロイヤルホテル(大阪)
- Year and Date
  2010-09-23
- Data Source
  KAKENHI-PROJECT-22240090
[Presentation] 癌細胞におけるオートファジー経路の障害.第69回日本癌学会学術総会2010
- Author(s)
  井上純、稲澤譲治
- Organizer
  第69回日本癌学会学術総会
- Place of Presentation
  大阪国際会議場・リーガロイヤルホテル(大阪)
- Year and Date
  2010-09-23
- Data Source
  KAKENHI-PLANNED-22134002
[Presentation] Lysosomal-associated protein multispanning transmembrane 5 gene (LAPTM5) is associated with spontaneous regression of neuroblastomas2010
- Author(s)
  井上純、稲澤譲治, 他
- Organizer
  101th annual meeting of American Association for Cancer Research 2010
- Place of Presentation
  Washington, DC, USA
- Data Source
  KAKENHI-PLANNED-22134002
[Presentation] Lysosomal-associated protein multispanning transmembrane 5 gene(LAPTM5) is associated with spontaneous regression of neuroblastomas2010
- Author(s)
  Inoue J, Misawa A, Tanaka Y, Ichinose S, Sugino Y, Hosoi H, Sugimoto T, Imoto I, Inazawa J
- Organizer
  101th annual meeting of American Association for Cancer Research 2010
- Place of Presentation
  Washington, DC, USA
- Data Source
  KAKENHI-PROJECT-22790309
[Presentation] 癌におけるオートファジー障害2010
- Author(s)
  井上純
- Organizer
  日本癌学会
- Place of Presentation
  大阪リーガロイヤルホテル
- Year and Date
  2010-09-24
- Data Source
  KAKENHI-PROJECT-22790309
[Presentation] マイクロRNAを基盤としたNRF2活性化癌に対する診断・治療法の確立
- Author(s)
  井上純、山本信祐、藤原直人、河野辰幸、小村健、小崎健一、稲澤譲治
- Organizer
  第73回日本癌学会学術総会
- Place of Presentation
  横浜・パシフィコ横浜
- Year and Date
  2014-09-25 – 2014-09-27
- Data Source
  KAKENHI-PROJECT-24590372
[Presentation] 食道癌におけるLAPTM5の不活性化
- Author(s)
  ヌイラン・ミッシェル、井上純、河野辰幸、稲澤譲治
- Organizer
  第73回日本癌学会学術総会
- Place of Presentation
  横浜・パシフィコ横浜
- Year and Date
  2014-09-25 – 2014-09-27
- Data Source
  KAKENHI-PROJECT-24590372
[Presentation] p62/SQSTM1タンパク質の高発現は子宮体癌の悪性形質および不良な予後と相関する
- Author(s)
  岩舘怜子、井上純、津田均、平沢晃、青木大輔、稲澤譲治
- Organizer
  第73回日本癌学会学術総会
- Place of Presentation
  横浜・パシフィコ横浜
- Year and Date
  2014-09-25 – 2014-09-27
- Data Source
  KAKENHI-PROJECT-24590372
[Presentation] ヒト癌におけるオートファジー関連遺伝子の異常.
- Author(s)
  井上純、稲澤讓治
- Organizer
  第71回日本癌学会学術総会
- Place of Presentation
  さっぽろ芸文館(北海道)
- Data Source
  KAKENHI-PROJECT-22240090
[Presentation] 癌治療におけるオートファジー活性の評価．
- Author(s)
  井上純、稲澤譲治
- Organizer
  第72回日本癌学会学術総会
- Place of Presentation
  パシフィコ横浜．神奈川
- Data Source
  KAKENHI-PLANNED-22134002
[Presentation] マイクロRNAを基盤としたNRF2活性化癌に対する診断・治療法の確立
- Author(s)
  井上純、稲澤譲治
- Organizer
  第18回日本がん分子標的治療学会学術集会
- Place of Presentation
  仙台市情報産業プラザ
- Year and Date
  2014-06-25 – 2014-06-27
- Data Source
  KAKENHI-PROJECT-24590372
[Presentation] 癌治療におけるオートファジー活性の評価．
- Author(s)
  井上純、稲澤譲治
- Organizer
  第72回日本癌学会学術総会
- Place of Presentation
  パシフィコ横浜．神奈川
- Data Source
  KAKENHI-PROJECT-25640062
[Presentation] 新規癌抑制性microRNAとしてのMir-634の同定
- Author(s)
  藤原直人、井上純、河野辰幸、小崎健一、稲澤譲治
- Organizer
  第73回日本癌学会学術総会
- Place of Presentation
  横浜・パシフィコ横浜
- Year and Date
  2014-09-25 – 2014-09-27
- Data Source
  KAKENHI-PROJECT-24590372
[Presentation] 癌治療におけるオートファジー活性の評価．
- Author(s)
  井上純、稲澤譲治
- Organizer
  第72回日本癌学会学術総会
- Place of Presentation
  パシフィコ横浜．神奈川
- Data Source
  KAKENHI-PROJECT-25250019

1. INAZAWA Johji (30193551)

# of Collaborated Projects: 7 results

# of Collaborated Products: 82 results
2. TANIMOTO Kosuke (60611613)

# of Collaborated Projects: 4 results

# of Collaborated Products: 1 results
3. KOZAKI Ken-ichi (50270715)

# of Collaborated Projects: 3 results

# of Collaborated Products: 1 results
4. Muramatsu Tomoki (90732553)

# of Collaborated Projects: 3 results

# of Collaborated Products: 7 results
5. 玄泰行 (80596156)

# of Collaborated Projects: 2 results

# of Collaborated Products: 14 results
6. 井本逸勢 (30258610)

# of Collaborated Projects: 1 results

# of Collaborated Products: 0 results
7. 森崇 (40402218)

# of Collaborated Projects: 1 results

# of Collaborated Products: 0 results
8. 橘逸勢

# of Collaborated Projects: 0 results

# of Collaborated Products: 1 results
9. 赤松秀輔

# of Collaborated Projects: 0 results

# of Collaborated Products: 3 results

INOUE Jun 井上 純

Research Projects

Research Products

Co-Researchers

Optimization of miRNA therapeutics for clinical applicationPrincipal Investigator

Principal Investigator

Project Period (FY)

Research Category

Review Section

Research Institution

Development of therapeutic strategy based on autophagy activity for cancer therapyPrincipal Investigator

Principal Investigator

Project Period (FY)

Research Category

Review Section

Research Institution

Development of therapeutic miRNAs targeting BET family protein BRD4 for cancer

Principal Investigator

Project Period (FY)

Research Category

Review Section

Research Institution

Development of therapeutic strategy based on autophagy activity for cancer therapyPrincipal Investigator

Principal Investigator

Project Period (FY)

Research Category

Research Field

Research Institution

Establishment of novel concept for cancer diagnostics and therapeutics based on the systematic comprehension of cellular context in cancer

Principal Investigator

Project Period (FY)

Research Category

Review Section

Research Institution

Comprehensive understanding of molecular carcinogenesis through omics analysis and development of molecular diagnostics for personalized medicine

Principal Investigator

Project Period (FY)

Research Category

Research Field

Research Institution

Chromothripsis-like pattern in cancer-cell genome after irradiation by a focused vertical micro-beam system, SPICE

Principal Investigator

Project Period (FY)

Research Category

Research Field

Research Institution

Molecular mechanism of the spontaneous regression of neuroblastomaPrincipal Investigator

Principal Investigator

Project Period (FY)

Research Category

Research Field

Research Institution

Integrative omics analysis to explore molecular targets and biomarkers for personalized medicine in cancer

Principal Investigator

Project Period (FY)

Research Category

Review Section

Research Institution

Development of diagnostic tools for personalized cancer medicine by genomic and epigenomic analyses

Principal Investigator

Project Period (FY)

Research Category

Research Field

Research Institution

Molecular mechanism of the spontaneous regression of neuroblastomaPrincipal Investigator

Principal Investigator

Project Period (FY)

Research Category

Research Field

Research Institution

[Book] 医学の歩み：マイクロRNAを用いた核酸抗癌薬の開発2019

Author(s)

Total Pages

Publisher

ISBN

Data Source

[Journal Article] Potential for reversing miR-634-mediated cytoprotective processes to improve efficacy of chemotherapy against oral squamous cell carcinoma2022

Author(s)

Journal Title

DOI

INOUE Jun 井上純